INSPIRATION HEALTHCARE GROUP PLC - Full year results briefing

Inspiration Healthcare Group plc delivered a strong FY2026 investor update, reporting record financial results driven by robust growth in its neonatal ventilation business and improved operational efficiency. Revenue increased 24% year-on-year, supported by major international contracts and a 10% rise in underlying organic sales, while gross margins improved to 43.7%. Adjusted EBITDA rose significantly from £0.2 million to £2.8 million, reflecting stronger profitability, disciplined cost control, and successful execution of the company’s “Back to Basics” strategy. The group generated strong operating cash flow, reduced inventory by 33%, and lowered net debt to £5.1 million, strengthening its balance sheet and financial flexibility. Management highlighted growing momentum across its core SLE neonatal ventilation division, which achieved 56% revenue growth and continues to benefit from expanding international demand, market leadership within the NHS, and a growing order book. The company is also progressing key strategic initiatives, including the launch of proprietary consumables, expansion of recurring service revenues, and development of products for the US market, with FDA submission targeted for 2027. Inspiration Healthcare’s growth strategy remains focused on increasing market share in neonatal care, enhancing recurring revenue streams, and leveraging operational efficiencies to improve margins. With a strong opportunity pipeline, growing international presence, ongoing product innovation, and positive trading at the start of FY2027, management remains confident in delivering sustainable revenue growth, improved profitability, and long-term shareholder value.